IPO Details
Bidding Dates
To be announced
Minimum Investment
To be announced
Price Range
To be announced
Maximum Investment
To be announced
Retail Discount
To be announced
Issue Size
₹1,225 Cr
Investor category and sub category
Qualified Institutional Buyers (QIB) | Retail Individual Investors (RII) | Non-institutional Investors (NII)About Anjali Labtech IPO
Anjali LabTech Limited IPO is a book building issue of ₹1,225.00 crores, consisting of a fresh issue of shares worth ₹925.00 crores and an offer for sale of ₹300.00 crores.
The equity shares are proposed to be listed on NSE and BSE. IIFL Capital Services Limited is the book running lead manager, and MUFG Intime India Private Limited is the registrar of the issue. Key details, such as IPO dates, IPO price bands, and lot size, are yet to be announced.
About Anjali LabTech Limited
Anjali LabTech Limited was originally incorporated as Anjali Diamonds Private Limited on May 15, 2021, under the provisions of the Companies Act, 2013, in Gujarat. The company changed its name to Anjali LabTech Private Limited on July 2, 2025. Subsequently, it was converted into a public limited company and renamed Anjali LabTech Limited, with a fresh certificate of incorporation issued on July 22, 2025.
The company is headquartered in Surat, Gujarat, and operates in the lab-grown diamond (LGD) industry, with business operations spanning the manufacturing of diamond-growing machinery, growing and processing of lab-grown diamonds, jewellery manufacturing, and related services. The company operates through a vertically integrated business model covering multiple stages of the lab-grown diamond value chain.
Its business includes designing, manufacturing, and supplying Microwave Plasma Chemical Vapour Deposition (MPCVD) machines to third-party customers, as well as installing these machines for captive production of rough lab-grown diamonds. Its operations also include processing rough lab-grown diamonds into polished lab-grown diamonds, manufacturing and selling LGD-studded jewellery, and providing colour enhancement services using High Pressure High Temperature (HPHT) technology.
Its product portfolio includes MPCVD machines, rough and polished lab-grown diamonds, diamond wafers, LGD-studded jewellery, and MPCVD machine components. The company also provides specialised colour enhancement services for rough lab-grown diamonds supplied by third-party customers. Its manufacturing capabilities extend to producing smaller lab-grown diamonds below one carat using its proprietary MPCVD machines.
During Fiscal 2026, the company also commenced manufacturing and supplying MPCVD machine parts using Computer Numerical Control (CNC) machines, expanding its product portfolio beyond its existing diamond-related offerings.
The company operates seven manufacturing facilities, all located in Surat, Gujarat, India. These facilities include MPCVD machine manufacturing and robotic polishing units, rough lab-grown diamond growing facilities, rough diamond processing and polishing facilities, and an HPHT-based colour enhancement facility.
Its manufacturing infrastructure supports operations across machinery production, diamond growing, processing, polishing, and jewellery manufacturing. The company's centralised manufacturing presence in Surat provides access to the region's established diamond industry ecosystem and skilled workforce.
As of March 31, 2026, the company's installed manufacturing capacity included 3,000 MPCVD machines, rough lab-grown diamond growing capacity of 14,48,640 carats, polished lab-grown diamond processing capacity of 7,20,000 carats, and LGD-studded jewellery manufacturing capacity of 144 kilograms.
The company also uses robotic systems for polishing rough lab-grown diamonds weighing up to two carats, while larger diamonds are processed through a combination of manual craftsmanship and automation. As of March 31, 2026, the company was estimated to have a 36% global market share by volume in MPCVD machine manufacturing, according to the industry report cited in the prospectus.
As of March 31, 2026, the company served 2,253 customers, including 1,446 domestic customers and 807 customers located outside India. Its customer base includes MPCVD machine manufacturers and buyers, diamond traders, jewellery manufacturers, retail chains, and independent jewellery retailers.
Some of its customers include entities belonging to the Kiran Group, Evermine Diamond Private Limited, Karva Trading, DS Diamonds, Nanlaksh Tech Group Limited, Parishi Jewels, Tobias Designs Limited, GIVA, Auclair Lifestyle Private Limited, RÉIA, Firefly, and Palmonas. During Fiscal 2026, the company exported its products to 23 countries, generating export revenue of ₹2,099.43 million.
Industry Outlook
- The global lab-grown diamond (LGD) industry is witnessing rapid expansion, driven by increasing demand for affordable, sustainable, and socially responsible alternatives to natural diamonds. Global LGD production is expected to reach 37–38 million carats in Fiscal 2026, accounting for approximately 22% of total diamond supply.
- India has emerged as a major global manufacturing hub for lab-grown diamonds, with estimated production of 17–19 million carats in Fiscal 2026, representing approximately 45–50% of global LGD output. India's established diamond processing ecosystem, skilled workforce, and growing manufacturing capabilities support its position in the global market.
- India's rough lab-grown diamond market has expanded significantly, growing at an estimated compound annual growth rate (CAGR) of 46–60% from 1–2 million carats in Fiscal 2020 to 17–19 million carats in Fiscal 2026. The market is projected to grow at a CAGR of 21–24% to reach 40–41 million carats by Fiscal 2030.
- Lab-grown diamonds are primarily manufactured using two technologies: Microwave Plasma Chemical Vapour Deposition (MPCVD) and High Pressure High Temperature (HPHT). MPCVD generally enables the production of larger, high-clarity diamonds, particularly those exceeding one carat, while HPHT typically produces smaller gem-grade diamonds. Technological improvements in MPCVD have enhanced production efficiency, diamond quality, and cost competitiveness.
- India has emerged as a global leader in MPCVD technology, accounting for approximately 87% of global MPCVD machine manufacturing in Fiscal 2026, with around 13,700 operational machines. Approximately 40–50 domestic manufacturers operate in this ecosystem, while the top five manufacturers collectively account for around 80% of the domestic market.
- Surat, traditionally known for natural diamond cutting and polishing, has evolved into a major centre for lab-grown diamond production. The city accounts for approximately 90% of India's LGD output and houses around 85–90% of the country's MPCVD machines. Its skilled workforce, established diamond trading ecosystem, manufacturing infrastructure, and access to trained personnel support the industry's growth.
- India's exports of rough and polished lab-grown diamonds increased from 11.3 million carats in Fiscal 2024 to 19.9 million carats in Fiscal 2026. During this period, rough LGD exports recorded a CAGR of approximately 9%, while polished LGD exports grew at 43%. Increasing international demand and improvements in domestic production and processing capabilities have supported India's export growth.
- Beyond jewellery, lab-grown diamonds are gaining importance in industrial applications, particularly electronics, semiconductors, optics, and thermal management. MPCVD-produced diamond substrates offer potential advantages in industrial applications, creating additional demand for advanced manufacturing equipment. Research and development initiatives are also exploring applications of CVD technology in green hydrogen production and advanced materials, providing opportunities for the industry's long-term diversification.
Anjali LabTech IPO Objectives
The company proposes to utilise the net proceeds from the issue towards the following objectives:
- Funding capital expenditure for the manufacturing and captive installation of MPCVD machines to facilitate in-house growing of rough LGDs.
- Funding capital expenditure for construction and development of Anjali Corporate House at Moje Kosmada, Surat, Gujarat.
- Prepayment or re-payment of a portion of certain outstanding borrowings availed by the company.
- Towards general corporate purposes.
Financial Performance of Anjali LabTech Limited
Particulars | FY26 | FY25 | FY24 |
Revenue from operations (₹ lakh) | 6,15,513.00 | 4,72,500.00 | 2,23,187.00 |
EBITDA (₹ lakh) | 2,64,215.00 | 1,84,636.00 | 1,09,871.00 |
EBITDA Margin (%) | 42.93% | 39.08% | 49.23% |
PAT (₹ lakh) | 2,00,923.00 | 1,46,788.00 | 90,061.00 |
PAT Margin (%) | 32.18% | 30.68% | 39.52% |
Net Worth (₹ lakh) | 5,18,799.00 | 3,18,528.00 | 1,72,339.00 |
RoNW (%) | 47.99% | 59.81% | 70.51% |
RoCE (%) | 46.23% | 58.04% | 80.93% |
Anjali Labtech Limited Peer Details Comparison
Name of the Company | Consolidated / Standalone | Face Value (₹ per share) | Revenue from Operations (₹ lakhs) | Basic EPS (₹) | Diluted EPS (₹) | NAV (₹ per share) | P/E Ratio | RoNW (%) | PAT Margin (%) |
Anjali LabTech Limited | Consolidated | 5.00 | 6,15,513.00 | 13.40 | 13.40 | 34.60 | NA | 48.01% | 32.18% |
Goldiam International Limited | Consolidated | 2.00 | 9,76,857.00 | 15.11 | 15.43 | 97.95 | 21.18 | 18.40% | 16.70% |
Strengths and Opportunities of Anjali Labtech IPO
1. Anjali LabTech operates across the entire lab-grown diamond value chain, including designing and manufacturing MPCVD machines, growing rough lab-grown diamonds, processing and polishing diamonds, and selling diamond-studded jewellery. This integration supports better quality control, operational coordination and cost efficiency.
2. The company had an estimated 36% global market share and approximately 41% share of the Indian MPCVD machine market by volume as of March 31, 2026. It had cumulatively manufactured 5,635 MPCVD machines, of which 4,875 were sold to third parties.
3. The company generates revenue from MPCVD machines, rough and polished lab-grown diamonds, and lab-grown diamond-studded jewellery. It served 2,253 customers in FY26, compared with 1,786 in FY25 and 848 in FY24, reflecting an expanding customer base.
4. Its R&D initiatives have supported improvements such as seed reuse to reduce raw material costs, in-house development of machinery components to improve equipment uptime, and the expansion of its product portfolio to include diamond wafers and below-one-carat lab-grown diamonds.
5. Global lab-grown diamond production is estimated to reach 37–38 million carats in FY26, while India's rough lab-grown diamond market is projected to grow at a CAGR of 21–24% and reach 40–41 million carats by FY30. This provides an opportunity for the company to benefit from rising demand for MPCVD machines and lab-grown diamonds.
6. The company plans to increase its captive MPCVD machine capacity, including the proposed installation of 1,800 machines at its Aasta facility. The expansion could support growth in diamond wafers used in semiconductors, electronics, optics and thermal management. The lab-grown diamond substrate-based semiconductor market is projected to grow from US$190 million in CY25 to US$334 million by CY30, at a CAGR of 12%.
Risks and Threats of Anjali Labtech IPO
1. The company is exposed to supplier concentration and import dependency for key MPCVD components. Its top 10 suppliers account for approximately 90.85% of the estimated procurement cost for the proposed expansion, while suppliers in China and the United States account for a significant portion of its sourcing. Supply-chain disruptions, geopolitical tensions, tariffs and currency fluctuations could increase costs or delay production.
2. The company’s business is exposed to US tariffs and international trade restrictions. Since it exports lab-grown diamonds and operates internationally through its US subsidiary, changes in tariffs, trade policies or diplomatic relations could affect its export competitiveness, sales, profitability and cash flows.
3. The proposed expansion involves substantial capital expenditure and execution risks. The company plans to manufacture and install 1,800 MPCVD machines at its Aasta facility, involving estimated component procurement costs of ₹5,245.59 million. Cost escalations, delays in procurement, labour shortages, installation issues or regulatory approvals could delay the project and affect its expected benefits.
4. The company operates in a competitive and technology-intensive industry. MPCVD manufacturing requires significant capital investment, technical expertise and continuous R&D. Competition from Indian and Chinese manufacturers, pricing pressure, technological advancements and the risk of intellectual property leakage could affect its market position and margins.
5. The company's operations depend on specialised technology, technical expertise and consistent production quality. Maintaining precise plasma conditions, gas composition, temperature and pressure is essential for producing diamonds of consistent quality. Variations in production yield, equipment performance or machine downtime could increase costs and adversely affect profitability.
6. The company faces intellectual property protection risks. Its competitive position relies on proprietary manufacturing processes, trade secrets, machine designs and diamond-growing techniques. Inadequate protection against unauthorised use, imitation or infringement claims could weaken its technological advantage and expose it to legal expenses and potential financial liabilities.
Anjali Labtech IPO Reservation
Investor Category | Shares Offered |
QIB Shares Offered | Not more than 50% of the Net Issue |
NII Shares Offered | Not less than 15% of the Net Issue |
Retail Shares Offered | Not less than 35% of the Net Issue |
Anjali Labtech IPO Promoter Holding
The promoters of the company are Rajnikant M Radadiya and Sandipbhai Madhubhai Radadiya.
Share Holding Pre-Issue | 99.53% |
Share Holding Post Issue | - |
Anjali Labtech IPO Prospectus
Anjali Labtech IPO Registrar and Lead Managers
Anjali Labtech IPO Lead Managers
IIFL Capital Services Limited
Axis Capital Limited
Registrar for Anjali Labtech IPO
MUFG Intime India Private Limited
Contact Number: 022-49186000
Anjali Labtech IPO Registrar
How To Apply for Anjali Labtech IPO Online?
Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
Locate the IPO Section: Navigate to the 'IPO' section on the platform.
Select IPO: Find and select the Anjali Labtech IPO from the list of open IPOs.
Enter the Lot Size: Specify the number of lots you want to bid for.
Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.
How To Check the Allotment Status of the Anjali Labtech IPO?
Steps to check IPO allotment status on Angel One’s app:
Log in to the Angel One app.
Go to the IPO Section and then to IPO Orders.
Select the individual IPO that you had applied for and check the allotment status.
Angel One will notify you of your IPO allotment status via push notification and email.
Don't miss the next investment opportunity - browse the Upcoming IPO on Angel One.
Contact Details of Anjali Labtech IPO
Registered Office: Anjali House, 2nd & 3rd Floor, Plot No. 210-211, Opp. Gitanjali Petrol Pump, Varachha Road, Surat 395 006, Gujarat, India.
Phone: +91 261 255 4152
E-mail: sales@anjalidiamonds.com
- How to Apply in IPO
- How to Check IPO Allotment Status
Login to Angel One App / Website & click on IPO
Select desired IPO & tap on "Apply"
Enter UPI ID, set quantity/price & submit
Accept mandate on the UPI app to complete the process
Anjali Labtech IPO FAQs
What minimum lot size can retail investors subscribe to?
The minimum lot size for the Anjali Labtech IPO has not yet been announced.
When will the Anjali Labtech IPO be allotted?
The basis of allotment date for the Anjali Labtech IPO has not yet been announced.
How to increase your chances of getting a Anjali Labtech IPO allotment?
Multiple Submissions: Use different Demat accounts belonging to different eligible applicants to make separate applications.
Price Bidding: Opt for bidding at the cut-off price or the upper price band to avoid the application being rejected due to a lower bid.
Timely Subscription: Ensure you submit your IPO application within the specified subscription period and complete the required application process before the deadline.
Application Details: Check your PAN, Demat account, bank account and UPI details carefully before submitting the application to avoid rejection due to errors.
How do I approve the UPI mandate request for the Anjali Labtech IPO?
After submitting your IPO application, you will receive a UPI mandate request in your chosen UPI app. Review the details and approve the mandate before the specified deadline to complete your application.
Can I submit more than one application for the public issue of Anjali Labtech Limited using one PAN?
No, you should not submit multiple IPO applications using the same PAN under the same investor category. Multiple applications with the same PAN may be rejected as invalid during the allotment process.
What is 'pre-apply' for Anjali Labtech Limited IPO?
Pre-apply allows investors to submit their IPO application before the public issue officially opens for subscription. The application is saved in advance and is processed when the IPO opens.
If I pre-apply for the Anjali Labtech Limited IPO, when will my order get placed?
The IPO opening date for Anjali Labtech Limited has not yet been announced. Thus, the order placement date cannot be specified.
When will I know if my Anjali Labtech Limited IPO order is placed?
You will receive a confirmation once your IPO order has been successfully placed on the exchange. You will also receive notifications through your email and SMS.
Where is the Anjali Labtech Limited IPO getting listed?
The Anjali Labtech Limited IPO is proposed to be listed on the BSE and NSE platforms. The listing date has not yet been announced.








